Registration of the substance

Iron Oxides REACH Consortium

Letter of Access for the registration of the substance(s):

Dear Sirs,

The Members of the for the registration of the substance under REACH1 (here thereafter referred to as “Consortium ”) agree that the data, studies, summaries, waiving argumentations, reasoning of testing proposals and/or assessments specified in detail below, either jointly or individually owned by and/or licensed to the Members of the Consortium and submitted by its Member the Lead Registrant in support of the registration under REACH of substance (hereinafter collectively referred to as the “Dossier”), may be referred to, pursuant to Article 10 (a) last para. REACH, (or Articles 17 (2) second last para, or 18 (2) second last para. respectively for Intermediates) by the Applicant.

LoA will be issued per group of companies. Please fill in the application form only once for all affiliated group companies.

Please give full company details of legal entity:
Company Name
REACH-IT UUID Number:
Company reference name or number (optional)
Country
VAT number
If you do not fill out a VAT number, you will be charged 21%.
Street Line 1
Street Line 2
Postal Code
City
Please give full details of person authorized to make the application:
First Name
Last Name
Gender
  • Male
  • Female
Phone Number
Fax Number
Email
Please give full company details for all affiliates to be covered by this Letter of Access:
Affiliates:
ex. The Great Chemical Manufacturing Co. Ltd; 95130 Paris, 23 Molecule Avenue
In his registration, the Applicant acts:
  1. for himself
  2. as Only Representative pursuant to Article 8 REACH for the following non-EU manufacturer;
    Please give full contact details of non-EU legal entity represented by Only Representative

    If you act on behalf of several non-EU legal entities that are not related to each other, please fill in new application form for each of your principals.

    Company Name
    Country
    Street Line 1
    Street Line 2
    Postal Code
    City
    First Name
    Last Name
    Gender
    • Male
    • Female
    Phone Number
    Fax Number
    Email
  3. as Third Party Representative2 pursuant to Article 4 REACH.

    Do you want to disclose the name of the party you represent?

    1. Yes
    2. No
    Company Name
    REACH-IT UUID Number:
    Country
    Street Line 1
    Street Line 2
    Postal Code
    City
    First Name
    Last Name
    Gender
    • Male
    • Female
    Phone Number
    Fax Number
    Email
Applicable Joint Submission:

Mandatory and voluntary joint parts including CSR3 of Dossier (Article 10 (a) (iv), (vi), (vii) (ix) REACH)

Choose tonnage (required)

  1. Above 1000 ton
  2. 100 to 1000 ton
  3. Up to 100 ton
  4. Up to 10 ton

Restrictions (optional)

  1. No CSR (Voluntary joint parts of Dossier (Chemical Safety Report, Exposure Scenarios, Guidance on Safe Use) (Article 10 (a) (v), (viii), (b) REACH);)

Is the company to be invoiced the same as the legal entity registering under REACH?
  1. Yes
  2. No
Please give full company details of legal entity to be invoiced:
Company Name
Country
VAT number
If you do not fill out a VAT number, you will be charged 21%.
Street Line 1
Street Line 2
Postal Code
City
Legal Terms of Agreement:
The right to refer to the Joint Registration Dossier is subject to the following restrictions:
  1. The right of referral only gives access to the Joint Registration Dossier of the substance for the registration as specified above.
  2. The right of referral is solely granted in favor of the Applicant (and, only where applicable, the Affiliates listed herein), and is not transferable to any other entity or person.
  3. Unless otherwise specified below at 6., the Applicant is not authorized to receive any copies of the Joint Registration Dossier nor is the Applicant authorized to inspect or view the Joint Registration Dossier or any related specific document in whole or in part, outside the general inspection period granted by the Consortium and outside the conditions set out in the SIEF Agreement.
  4. This Letter of Access shall in no event be construed as granting the Applicant any property rights whatsoever in the Joint Registration Dossier.
  5. Nothing in this letter shall require the Consortium members to file any additional data.
  6. In as far as the Joint Registration Dossier may contain a chemical safety report (“CSR”) and guidance on safe use, and the Applicant is participating in joint submission for those parts of the dossier, or has otherwise acquired rights to them, those will be made available to the Applicant as needed and may be used by it in as far as needed for purposes of safe handling and elaboration of eSDS and must be filed by it individually if set out in the SIEF Agreement.
  7. If the Applicant has chosen to prepare itself the CSR, exposure scenarios and guidance on safe use, but does otherwise fully participate in the Joint Registration Dossier, it shall receive an electronic copy of parts Article 10 (a) (iv), (vi), (vii) and (ix) REACH of the Joint Registration Dossier and shall have the rights to use for this purpose only the (robust) study summaries and other information contained therein as well as to refer to the full study reports on which basis the (robust) study summaries have been developed.
  8. In any event and regardless of the rights and restrictions set forth above, the Applicant shall always receive a list of uses which are covered by the CSR, the proposed classification and labeling as well as the PNECs and DNELs.

This Letter of Access does not create any rights for third parties or any liability towards third parties in relation to the data for which access is granted.

Authorized Representative of the Consortium.

Applicant’s certifications and undertakings:
  • The Applicant hereby declares that it is aware of, agrees and complies with the provisions of the SIEF Agreement issued by the Lead Registrant, which shall apply in its entirety in addition to the provisions set out hereunder.
  • In case the Applicant has applied for an intermediate LoA only, the Applicant hereby declares that it is aware that registration as an intermediate pursuant to Articles 17 and 18 REACH is conditional upon fulfillment of the conditions set out there under.
  • The Applicant declares that it has wired the Letter of Access Pre-payment fee to the following bank account within 30 calendar days of signature of this Letter of Access. The joint token will be issued after receipt of the pre-payment. The invoice for the Letter of Access / Joint Submission will be issued after pre-payment has been received, but at the latest at the end of the applicable year of registration (end 2010, end 2013, end of 2018, as the case may be).

I have read and I agree with the legal Terms of the Agreement.


  1. Regulation (EC) No. 1907/2006; as may be amended from time to time. back

  2. If you choose not to disclose the Third Party represented, MLA reserves the right to appoint a neutral party that is entitled to audit the accuracy of the Third Party Representative's submission whilst guaranteeing the confidentiality of the Third Party. The Third Party Representative hereby agrees to such third party audit. back

  3. LoA applicants will be informed by separate email or via SIEF communication if the CSR and guidance on safe use will be prepared jointly and also submitted jointly, or rather whether they will be prepared jointly but will have to be submitted individually. In the latter case, LoA applicants will receive the CSR and guidance on safe use via a Iuclid so-called "export file" and must then insert it themselves into their individual REACH registration. back